Status:
UNKNOWN
Maternal and Neonatal Outcome in Severe Preeclampsia
Lead Sponsor:
Aljazeera Hospital
Collaborating Sponsors:
Cairo University
Conditions:
Pre-Eclampsia
Eligibility:
FEMALE
20-42 years
Brief Summary
In normal pregnancy the spiral arteries in the placental bed are invaded by trophoblast, which becomes incorporated into the vessel wall and replaces the endothelium, muscular layer and neural tissue
Detailed Description
Preeclampsia is considered severe if one or more of the following: 1. Blood pressure of 160mmHg systolic or high or 110mmHg diastolic or high on two occasions at least 6 hours a part while the patien...
Eligibility Criteria
Inclusion
- • All women with severe preeclampsia
Exclusion
- • History of epilepsy.
- Patients with chronic hypertension.
- Patients with renal disease.
Key Trial Info
Start Date :
February 10 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04126122
Start Date
February 10 2019
End Date
February 1 2020
Last Update
October 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aljazeera( Al Gazeera) hospital
Giza, Egypt